These results demonstrate that the molecular knockdown of mitochondrial Ca2+ signaling impairs rapid tumor progression and metastasis formation in vivo, and well match the data of Fig 1, which showed overexpression of MCU in advanced clinical stages of breast cancer. Here, MCU is linked to breast carcinoma.